ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

494 hedge funds and large institutions have $22.6B invested in Alnylam Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 166 increasing their positions, 158 reducing their positions, and 44 closing their positions.

Holders
494
Holders Change
+45
Holders Change %
+10.02%
% of All Funds
7.24%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
95
Increased
166
Reduced
158
Closed
44
Calls
$267M
Puts
$321M
Net Calls
-$54.7M
Net Calls Change
-$24.4M

Top Buyers

1
Norges Bank
1
Norges Bank
Norway
$390M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$1.38B
3
Capital International Investors
3
Capital International Investors
California
$687M
4
Morgan Stanley
4
Morgan Stanley
New York
$309M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.29B

Top Sellers

1
Baillie Gifford & Co
1
Baillie Gifford & Co
United Kingdom
$1.33B
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.97B
3
Massachusetts Financial Services
3
Massachusetts Financial Services
Massachusetts
$21.5M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$667M
5
Capital World Investors
5
Capital World Investors
California
$3.1B
Name Market Value Shares Shares
Change 		Shares
Change %
Capital World Investors
1
Capital World Investors
California
$3.1B 16,174,563 -354,745 -2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.29B 11,943,895 +287,064 +2%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$1.97B 10,312,356 -969,050 -9%
BlackRock
4
BlackRock
New York
$1.63B 8,521,115 +128,111 +2%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$1.38B 7,214,198 +782,384 +12%
Baillie Gifford & Co
6
Baillie Gifford & Co
United Kingdom
$1.33B 6,967,097 -1,196,042 -15%
Dodge & Cox
7
Dodge & Cox
California
$703M 3,674,310 -72,845 -2%
Capital International Investors
8
Capital International Investors
California
$687M 3,586,657 +488,814 +16%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$667M 3,483,969 -441,035 -11%
T. Rowe Price Investment Management
10
T. Rowe Price Investment Management
Maryland
$656M 3,426,063 +27,204 +0.8%
State Street
11
State Street
Massachusetts
$597M 3,118,552 +219,039 +8%
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
$577M 3,016,141 -70,705 -2%
Capital Research Global Investors
13
Capital Research Global Investors
California
$561M 2,930,079 +146,236 +5%
Norges Bank
14
Norges Bank
Norway
$390M 2,039,798 +846,232 +71%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$368M 1,926,736 +87,231 +5%
RI
16
RTW Investments
New York
$314M 1,640,559 -42,803 -3%
Morgan Stanley
17
Morgan Stanley
New York
$309M 1,613,190 +403,807 +33%
ACA
18
Avoro Capital Advisors
New York
$213M 1,111,111 +100,000 +10%
Pictet Asset Management
19
Pictet Asset Management
Switzerland
$170M 885,585 +94,830 +12%
BG
20
Bellevue Group
Switzerland
$169M 885,318 -9,027 -1%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$160M 837,131 +47 +0%
Northern Trust
22
Northern Trust
Illinois
$146M 764,520 -33,180 -4%
Legal & General Group
23
Legal & General Group
United Kingdom
$145M 758,504 -36,167 -5%
UBS AM
24
UBS AM
Illinois
$142M 741,061 -33,415 -4%
Amundi
25
Amundi
France
$141M 711,692 +97,333 +16%
1
2 3 4 5